Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

TRACERx: preoperative ctDNA below 80 parts per million still marked worse survival in lung adenocarcinoma

In the January 13, 2025 Nature Medicine TRACERx analysis, lung adenocarcinomas with preoperative ctDNA detected below 80 parts per million still had worse overall survival than ctDNA-negative adenocarcinomas (HR 12.33; 95% CI 1.63 to 93.35).

Nature Medicine